The Klein Law Firm Reminds Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Ocular ...
July 17 2017 - 2:26PM
Business Wire
The Klein Law Firm announces the commencement of an
investigation of Ocular Therapeutix, Inc. (NASDAQ:OCUL) concerning
possible violations of federal securities laws.
On May 5, 2017, Ocular Therapeutix disclosed that the U.S. Food
and Drug Administration had found minor issues at its manufacturing
plant. However, on July 6, 2017, an article published by Seeking
Alpha claimed that Ocular Therapeutix’s management had been
misleading investors about manufacturing issues. One of the claims
made by the article is that more than 50% of lots manufactured by
Ocular Therapeutix contain bad product. Following this news, the
price of Ocular Therapeutix shares fell $0.68 per share or over 6%
to close at $9.50 per share on July 6, 2017.
If you suffered a loss in Ocular Therapeutix and wish to obtain
additional information, please contact Joseph Klein, Esq. by
telephone at 212-616-4899 or visit
http://www.kkclasslaw.com/OCUL-Info-Request-Form-176.
Joseph Klein, Esq. is an experienced attorney and has also
practiced as a Certified Public Accountant. Mr. Klein represents
investors and participates in securities litigations involving
financial fraud throughout the nation. Attorney advertising. Prior
results do not guarantee similar outcomes.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170717006072/en/
The Klein Law FirmJoseph Klein, Esq., (212) 616-4899Fax: (347)
558-9665www.kleinstocklaw.com
Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ocular Therapeutix (NASDAQ:OCUL)
Historical Stock Chart
From Apr 2023 to Apr 2024